Effect of neogard protection to reduce nasal injury in preterm infants receiving N-CPAP
Not Applicable
Recruiting
- Conditions
- asal injury associated with N-CPAP in preterm infants.Preterm [premature] newborn [other]P07.3
- Registration Number
- IRCT20191217045769N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Premature infants 32 weeks or less or premature infants weighing 1500 g or less who require N-CPAP
Parents are satisfied with the baby's entry into the study.
Exclusion Criteria
Premature infants who are >32 weeks of postmenstrual age (PMA) or Premature infants(<37 weeks(PMA)) at a weight <1500 g
The infant was intubated before receiving N-CPAP and received invasive ventilation
Preterm infants who had facial features that might preclude treatment with binasal CPAP (eg, cleft lip, Pierre Robin sequence,choanal atresia)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence and severity of nasal injury. Timepoint: Every 12 hours to 72 hours. Method of measurement: Check list.
- Secondary Outcome Measures
Name Time Method -CPAP failure or success rate. Timepoint: Time of removing neonatal from N-CPAP. Method of measurement: Check list.